Hematology-Oncology

Get The App!

Featured Programs

Reconsidering First Line PNH Treatment: Is There a Standard of Care?

New!

6 episodes

0.75 credit hours

Various Speakers

Early Relapse in Multiple Myeloma: Modern Management Strategies

10 episodes

1.00 credit hours

Various Speakers

Holding Court in Melanoma: Choosing the Optimal Frontline Treatment Approach for Stage IV...

4 episodes

0.75 credit hours

Various Speakers

Holding Court in Melanoma: Choosing the Optimal Adjuvant Treatment Approach for Stage III...

4 episodes

0.75 credit hours

Various Speakers

Test Your Knowledge:

First-Line Checkpoint Inhibitor Combinations in NSCLC in the Era of COVID-19

See More Quizzes

Featured Areas of Interest

Anticoagulation Management & Reversal Show all (34)

Keeping It Real: Reversing Effects of Anticoagulation in the Modern Era with Real World...

8 episodes

1.50 credit hours

Various Speakers

Highlights from ISTH 2023

10 episodes - non-certified

Various Speakers

The CAT is Out of the Bag: Real-World Data & Evidence-Based Medicine - Both Matter

7 episodes

1.00 credit hour

Various Speakers

Alternatives to Heparin...What Does the Future Hold?

2 episodes - non-certified

Various Speakers

Advanced Management of Life-Threatening Bleeding in the Anticoagulated Patient

6 episodes

1.00 credit hour

Various Speakers

Highlights from ISTH 2022

12 episodes - non-certified

Various Speakers

Looking Deep into Venous Thromboembolism - Addressing the Global Challenges

9 episodes - 1.50 credit hours Previously Certified

Various Speakers

The Bleeding Patient in the Emergency Department, Evidence-Based Approaches

2 episodes - 0.50 credit hours Previously Certified

Natalie Kreitzer, MD, MS

Managing Intracranial Hemorrhages in the Presence of Anticoagulation

3 episodes - 0.50 credit hours Previously Certified

Fred Rincon, MD, MSc, MBE

Case Studies in Hemorrhagic Stroke Management - What Should be Done?

4 episodes - 0.50 credit hours Previously Certified

Anmar Razak, MD

Time is Brain: The Management of Hemorrhagic Strokes and Role of Comprehensive Stroke...

7 episodes - 1.00 credit hour Previously Certified

Various Speakers

Translating CAT Guidelines into Everyday Practice During COVID-19

8 episodes - 1.25 credit hours Previously Certified

Various Speakers

Redefining the Coordination for VTE - Site of Care, Clinicians, and Patients – Part 2

10 episodes - 1.00 credit hour Previously Certified

Various Speakers

Redefining the Coordination for VTE - Site of Care, Clinicians, and Patients

12 episodes - 1.50 credit hours Previously Certified

Various Speakers

Casual and Educational Debriefs with Anticoagulation Experts at ISTH 2020

5 episodes - 1.25 credit hours Previously Certified

Various Speakers

ISTH 2020 Roundtable Discussions - Anticoagulation and Hemophilia

8 episodes - non-certified

Various Speakers

Highlights From ISTH 2020

22 episodes - non-certified

Various Speakers

COVID-19 and Hypercoagulability: Does this Pose a Threat of CTEPH in Susceptible...

2 episodes - non-certified

Richard Channick, MD & Victor Tapson, MD

Management of Life-Threatening Bleeding in the Anticoagulated Patient in the Emergency...

9 episodes - 2.75 credit hours Previously Certified

Various Speakers

Integrating Health Economics into Clinical Practice for the Reversal of an Anticoagulated...

6 episodes - 1.00 credit hour Previously Certified

Various Speakers

Holding Court in Anticoagulation Reversal

11 episodes - 2.00 credit hours Previously Certified

Various Speakers

Time is Brain: Managing Traumatic Brain Injuries for the Trauma Specialist

6 episodes - 1.75 credit hours Previously Certified

Various Speakers

2019 ASH Annual Meeting Highlights

11 episodes - non-certified

Various Speakers

Impacting Emergency Department Bleeds: The Change is Here and Now

9 episodes - 1.00 credit hour Previously Certified

Various Speakers

2019 ISTH Highlights in Thrombosis

29 episodes - non-certified

Various Speakers

Thrombosis

1 episodes - non-certified

Manesh R. Patel, MD

Updates in Bleeding Management and Reversal in the Emergency Room

4 episodes - 1.25 credit hours Previously Certified

Colin G. Kaide, MD, FACEP, FAAEM; Robert Takla, MD

Updates in Bleeding Management in Surgery and Trauma: Presented at the AAST Annual Meeting

4 episodes - 1.25 credit hours Previously Certified

Truman J. Milling Jr., MD, FACEP; Casey O'Connell, MD

Bleeding and DOACs

10 episodes - 1.25 credit hours Previously Certified

Jerrold H. Levy, MD, FAHA, FCCM

Highlights from THSNA 2018

5 episodes - non-certified

Various Speakers

Highlights from ISTH 2017

11 episodes - non-certified

Various Speakers

Highlights from AC Forum 2017

14 episodes - 1.75 credit hours Previously Certified

Various Speakers

Reversal Strategies for Patients Taking Novel Oral Anticoagulants (NOACs)

8 episodes - non-certified

Scott Kaatz, DO, MSc, FACP, SFHM et al.

Breaking the Barrier to Effective VTE Prevention in Medically Ill Patients

11 episodes - 1.00 credit hour Previously Certified

C. Michael Gibson, MS, MD

Immuno-Oncology Show all (48)

Holding Court in Melanoma: Choosing the Optimal Frontline Treatment Approach for Stage IV...

4 episodes

0.75 credit hours

Various Speakers

Holding Court in Melanoma: Choosing the Optimal Adjuvant Treatment Approach for Stage III...

4 episodes

0.75 credit hours

Various Speakers

Metastatic Melanoma: Solving Clinical Dilemmas in Frontline ICI Treatment

3 episodes

0.50 credit hours

Various Speakers

NSCLC Case by Case: Optimizing 1L Immunotherapy for Advanced & Metastatic Disease

6 episodes

1.50 credit hours

Various Speakers

Resectable Melanoma: New & Emerging Adjuvant Treatments

6 episodes

1.00 credit hour

Various Speakers

Treating Pediatric High-Risk cHL: Optimizing Care, Reducing Adverse Effects

5 episodes

0.50 credit hours

Various Speakers

Integrating Immune Checkpoint Therapy into Early-Stage Non-Small Cell Lung Cancer

15 episodes

2.50 credit hours

Various Speakers

Integrating Immune Checkpoint Therapy Into the Management of Resectable Melanoma

12 episodes

2.25 credit hours

Various Speakers

Implementing Data Into Practice: Late-Breaking Melanoma Highlights From the 2022 European...

6 episodes

0.75 credit hours

Various Speakers

Moving Forward in Esophageal Cancer: The Expanding Role of Checkpoint Inhibitors

7 episodes - 1.25 credit hours Previously Certified

Various Speakers

The Evolving Role of Immune Checkpoint Inhibitors in the First-Line Treatment of Advanced...

6 episodes - 1.00 credit hour Previously Certified

Various Speakers

Case Discussions in Advanced NSCLC: Selecting Frontline Immunotherapy

10 episodes - 1.50 credit hours Previously Certified

Various Speakers

Individualizing Patient Care Using Biomarker-Driven Cancer Immunotherapy

9 episodes - 1.50 credit hours Previously Certified

Various Speakers

Applying Evolving Treatment Strategies in Advanced Melanoma

7 episodes - 1.00 credit hour Previously Certified

Various Speakers

Highlights in GU Oncology from the 2021 Mid to Late Year Congresses: Implementing Data...

17 episodes - 2.50 credit hours Previously Certified

Various Speakers

Practice-Changing Highlights in Genitourinary Cancers - Data from the European Congress

5 episodes - 0.75 credit hours Previously Certified

Various Speakers

Practice-Changing Highlights in Advanced Melanoma - Data from the European Congress

3 episodes - 0.50 credit hours Previously Certified

Various Speakers

Practice-Changing Highlights in Gastric and Esophageal Cancers - Data from the European...

3 episodes - 0.50 credit hours Previously Certified

Various Speakers

Optimal Dosing of ICIs: A Look at Various Dosing Strategies Across Multiple Tumor Types

9 episodes - 2.25 credit hours Previously Certified

Various Speakers

Highlights in Upper GI Oncology from the 2021 Mid-Year Congress: Implementing Data into...

5 episodes - 1.00 credit hour Previously Certified

Various Speakers

Latest Immunotherapy Advances in RCC: Integrating Data from the 2021 Winter Meeting into...

6 episodes - 1.00 credit hour Previously Certified

Various Speakers

Immunotherapy Advances in Urothelial Cancer: Integrating Data from the Winter 2021...

7 episodes - 1.00 credit hour Previously Certified

Various Speakers

IO Advances in Upper Gl Cancers: Integrating Data from Fall 2020 Meetings into Clinical...

12 episodes - 2.00 credit hours Previously Certified

Various Speakers

Highlights in Hematologic Malignancies from the Winter 2020 Hematology Meeting -...

9 episodes - 1.25 credit hours Previously Certified

Various Speakers

Clinical Practice Implications and Highlights from the 62nd ASH Annual Meeting and...

6 episodes - non-certified

Various Speakers

The Evolving Role of Checkpoint Inhibitors as Frontline Treatment for Malignant Pleural...

7 episodes - 1.00 credit hour Previously Certified

Patrick Forde, MBBCh & Joshua Reuss, MD

IO On The GO Series: Clinical Questions and Latest Approaches in Hepatocellular Carcinoma...

5 episodes - 1.00 credit hour Previously Certified

Various Speakers

Advancing the Care of ß-thalassemia Patients with Novel Therapies

14 episodes - 1.75 credit hours Previously Certified

Various Speakers

Personalized Patient Immunotherapy: Integrating Biomarkers into Clinical Practice

12 episodes - 2.00 credit hours Previously Certified

Various Speakers

Ushering in Maintenance Therapy for AML

11 episodes - 1.75 credit hours Previously Certified

Various Speakers

Impacting Patient Outcomes in mRCC

9 episodes - 1.50 credit hours Previously Certified

Various Speakers

Changing the Treatment Paradigm for Patients with Intermediate- and Higher-Risk MDS

8 episodes - 1.25 credit hours Previously Certified

Various Speakers

Contemporary Challenges and New Approaches in Metastatic Melanoma

9 episodes - 1.75 credit hours Previously Certified

Various Speakers

Integrating and Optimizing Immunotherapy-Based Combinations in mccRCC

6 episodes - 1.25 credit hours Previously Certified

Various Speakers

Frontline Systemic Therapy for Metastatic Melanoma

7 episodes - 1.00 credit hour Previously Certified

Various Speakers

TKI’s and Immune Checkpoint Inhibitors: The New Foundation in Metastatic Clear-cell Renal...

13 episodes - 2.00 credit hours Previously Certified

Various Speakers

New and Emerging Approaches to Managing Lower-Risk MDS

10 episodes - 2.00 credit hours Previously Certified

Various Speakers

Highlights from the 2020 SOHO Meeting

10 episodes - non-certified

Various Speakers

Navigating First-Line Checkpoint Inhibitor Combinations in Non-Small Cell Lung Cancer...

12 episodes - 2.00 credit hours Previously Certified

Various Speakers

Advances in First-Line NSCLC: Integrating the Latest Congress Data into Clinical Practice

3 episodes - 0.50 credit hours Previously Certified

Various Speakers

Highlights from the 2020 Genitourinary Cancers Symposium - Immunotherapy in GU...

6 episodes - 1.00 credit hour Previously Certified

Various Speakers

Defining the Role of Immune Checkpoint Inhibitor Therapy in Advanced Hepatocellular...

9 episodes - 1.50 credit hours Previously Certified

Various Speakers

Innovative Solutions to Managing Treatment Related Adverse Events

7 episodes - 1.50 credit hours Previously Certified

Various Speakers

Recognizing and Managing Immunotherapy Related Adverse Events

8 episodes - 1.25 credit hours Previously Certified

Various Speakers

Cardiopulmonary and Vascular Toxicities Associated with Targeted and Immunotherapies

10 episodes - 1.50 credit hours Previously Certified

Various Speakers

Highlights from Oncology Nursing Society (ONS) 2019 – “Growing Together, Transforming...

12 episodes - non-certified

Various Speakers

Highlights from Oncology Nursing Society (ONS) 2018 – “One Nurse. One Moment. One Action”

10 episodes - non-certified

Various Speakers

Highlights from Oncology Nursing Society (ONS) 2017 – “Elevate Your Passion”

16 episodes - non-certified

Various Speakers

Gastrointestinal Cancers (GI) Show all (25)

Highlights from ISTH 2023

10 episodes - non-certified

Various Speakers

Alternatives to Heparin...What Does the Future Hold?

2 episodes - non-certified

Various Speakers

Targeting NRG1 Fusion Positive Tumors: An Actionable Oncogenic Driver to Outcomes

7 episodes - 1.00 credit hour Previously Certified

Various Speakers

Highlights from ISTH 2022

12 episodes - non-certified

Various Speakers

Moving Forward in Esophageal Cancer: The Expanding Role of Checkpoint Inhibitors

7 episodes - 1.25 credit hours Previously Certified

Various Speakers

The Evolving Role of Immune Checkpoint Inhibitors in the First-Line Treatment of Advanced...

6 episodes - 1.00 credit hour Previously Certified

Various Speakers

Individualizing Patient Care Using Biomarker-Driven Cancer Immunotherapy

9 episodes - 1.50 credit hours Previously Certified

Various Speakers

Practice-Changing Highlights in Gastric and Esophageal Cancers - Data from the European...

3 episodes - 0.50 credit hours Previously Certified

Various Speakers

Optimal Dosing of ICIs: A Look at Various Dosing Strategies Across Multiple Tumor Types

9 episodes - 2.25 credit hours Previously Certified

Various Speakers

Highlights in Upper GI Oncology from the 2021 Mid-Year Congress: Implementing Data into...

5 episodes - 1.00 credit hour Previously Certified

Various Speakers

Highlights in GI Cancers Presented at ASCO 2021

3 episodes - non-certified

Various Speakers

IO Advances in Upper Gl Cancers: Integrating Data from Fall 2020 Meetings into Clinical...

12 episodes - 2.00 credit hours Previously Certified

Various Speakers

IO On The GO Series: Clinical Questions and Latest Approaches in Hepatocellular Carcinoma...

5 episodes - 1.00 credit hour Previously Certified

Various Speakers

Personalized Patient Immunotherapy: Integrating Biomarkers into Clinical Practice

12 episodes - 2.00 credit hours Previously Certified

Various Speakers

Highlights from the 2020 Gastrointestinal Cancers Symposium - Immunotherapy in GI...

10 episodes - 1.50 credit hours Previously Certified

Various Speakers

Defining the Role of Immune Checkpoint Inhibitor Therapy in Advanced Hepatocellular...

9 episodes - 1.50 credit hours Previously Certified

Various Speakers

Innovative Solutions to Managing Treatment Related Adverse Events

7 episodes - 1.50 credit hours Previously Certified

Various Speakers

Recognizing and Managing Immunotherapy Related Adverse Events

8 episodes - 1.25 credit hours Previously Certified

Various Speakers

Cardiopulmonary and Vascular Toxicities Associated with Targeted and Immunotherapies

10 episodes - 1.50 credit hours Previously Certified

Various Speakers

GI Weekly: Outcomes 365

20 episodes - non-certified

Various Speakers

Oncology Nursing Weekly

1 episodes - non-certified

Various Speakers

GI Weekly Special Edition: 2019 Gastrointestinal Cancers Symposium

8 episodes - non-certified

Various Speakers

IMPACT Live GI Oncology Flip Classroom Training

4 episodes - non-certified

Johanna Bendell, MD

GI Weekly Special Edition: ASCO 2018

5 episodes - non-certified

Various Speakers

Highlights in Gastrointestinal Cancers (GI) from ASCO 2017

7 episodes - non-certified

Various Speakers

Genitourinary Cancers (GU) Show all (23)

Prostate Cancer: Focusing Androgen Receptor Inhibitors on High-Risk Localized & Locally...

7 episodes

0.75 credit hours

Various Speakers

Integrating Data Into Practice: Assessing the Latest Prostate Data From the 2023 Spring...

6 episodes

1.00 credit hour

Various Speakers

Antibody-Drug Conjugates: A New Option for Patients With Metastatic Urothelial Carcinoma

9 episodes

1.50 credit hours

Various Speakers

2022 Spring & Summer Conference Coverage: Integrating Prostate Cancer Data into Clinical...

5 episodes - 1.00 credit hour Previously Certified

Various Speakers

Androgen Deprivation Therapy in Prostate Cancer: Balancing the Risks and Benefits

9 episodes - 1.50 credit hours Previously Certified

Various Speakers

Highlights in GU Oncology from the 2021 Mid to Late Year Congresses: Implementing Data...

17 episodes - 2.50 credit hours Previously Certified

Various Speakers

Practice-Changing Highlights in Genitourinary Cancers - Data from the European Congress

5 episodes - 0.75 credit hours Previously Certified

Various Speakers

Optimal Dosing of ICIs: A Look at Various Dosing Strategies Across Multiple Tumor Types

9 episodes - 2.25 credit hours Previously Certified

Various Speakers

Advances in Castrate-Resistant Prostate Cancer (CRPC): Integrating Data into Clinical...

6 episodes - 1.00 credit hour Previously Certified

Various Speakers

Latest Immunotherapy Advances in RCC: Integrating Data from the 2021 Winter Meeting into...

6 episodes - 1.00 credit hour Previously Certified

Various Speakers

Immunotherapy Advances in Urothelial Cancer: Integrating Data from the Winter 2021...

7 episodes - 1.00 credit hour Previously Certified

Various Speakers

Patient Care in Kidney Cancer: What You Need to Know Along Your Journey

15 episodes - non-certified

Various Speakers

Personalized Patient Immunotherapy: Integrating Biomarkers into Clinical Practice

12 episodes - 2.00 credit hours Previously Certified

Various Speakers

Impacting Patient Outcomes in mRCC

9 episodes - 1.50 credit hours Previously Certified

Various Speakers

Integrating and Optimizing Immunotherapy-Based Combinations in mccRCC

6 episodes - 1.25 credit hours Previously Certified

Various Speakers

Advances in Genitourinary Cancers: Integrating Data into Clinical Practice and COVID-19...

5 episodes - 1.00 credit hour Previously Certified

Various Speakers

TKI’s and Immune Checkpoint Inhibitors: The New Foundation in Metastatic Clear-cell Renal...

13 episodes - 2.00 credit hours Previously Certified

Various Speakers

Highlights from the 2020 Genitourinary Cancers Symposium - Immunotherapy in GU...

6 episodes - 1.00 credit hour Previously Certified

Various Speakers

Innovative Solutions to Managing Treatment Related Adverse Events

7 episodes - 1.50 credit hours Previously Certified

Various Speakers

Recognizing and Managing Immunotherapy Related Adverse Events

8 episodes - 1.25 credit hours Previously Certified

Various Speakers

Cardiopulmonary and Vascular Toxicities Associated with Targeted and Immunotherapies

10 episodes - 1.50 credit hours Previously Certified

Various Speakers

Impacting Prostate Cancer Through New Approaches and Therapies

11 episodes - 1.50 credit hours Previously Certified

Daniel P. Petrylak, MD; Neal D. Shore, MD, FACS

Highlights from ASCO 2017

4 episodes - non-certified

Various

Bone Marrow/Stem Cell Transplantation Show all (15)

Applying Recent Evidence to the Management of Acute and Chronic GVHD

6 episodes - 1.25 credit hours Previously Certified

Iskra Pusic, MD, MSCI and Mark A. Schroeder, MD

Highlights in Hematologic Malignancies from the Winter 2020 Hematology Meeting -...

9 episodes - 1.25 credit hours Previously Certified

Various Speakers

Clinical Practice Implications and Highlights from the 62nd ASH Annual Meeting and...

6 episodes - non-certified

Various Speakers

Advancing the Care of ß-thalassemia Patients with Novel Therapies

14 episodes - 1.75 credit hours Previously Certified

Various Speakers

Personalized Patient Immunotherapy: Integrating Biomarkers into Clinical Practice

12 episodes - 2.00 credit hours Previously Certified

Various Speakers

Ushering in Maintenance Therapy for AML

11 episodes - 1.75 credit hours Previously Certified

Various Speakers

Changing the Treatment Paradigm for Patients with Intermediate- and Higher-Risk MDS

8 episodes - 1.25 credit hours Previously Certified

Various Speakers

New and Emerging Approaches to Managing Lower-Risk MDS

10 episodes - 2.00 credit hours Previously Certified

Various Speakers

Highlights from the 2020 SOHO Meeting

10 episodes - non-certified

Various Speakers

SOHO 2019 Annual Meeting - Cellular Therapy

1 episodes - non-certified

Various Speakers

Innovative Solutions to Managing Treatment Related Adverse Events

7 episodes - 1.50 credit hours Previously Certified

Various Speakers

Cardiopulmonary and Vascular Toxicities Associated with Targeted and Immunotherapies

10 episodes - 1.50 credit hours Previously Certified

Various Speakers

SOHO 2019 Meeting - Next Questions

11 episodes - non-certified

Various

The Role of JAK Inhibition in Graft-Versus-Host Disease (GVHD)

5 episodes - 1.00 credit hour Previously Certified

Mark A. Schroeder, MD

Recent Advances in the Treatment of Adult and Pediatric Patients with Hepatic...

9 episodes - 1.25 credit hours Previously Certified

Various Speakers